TABLE 1.
Demographics of medical weight management patients upon first obesity encounter who were able to achieve BMI <30 kg/m2 upon completion of program at 12 mo (N = 105)
| Demograhics including medical complications | Results | Confidence interval where applicable | Range and/or % where applicable |
|---|---|---|---|
| Age (y) | 45.2 | 95% CI ± 1.9 | Range: 23–60 |
| Gender | 94 F; 10 M; 3 missing data | 92.1% F | |
| Race and ethnicity | 83 White; 14 Black; 5 Hispanic; 2 unknown (80.6% White) | ||
| Initial weight (lb) | 221.4 | 95% CI ± 4.60 | |
| Initial BMI (kg/m2) | 36.4 | 95% CI ± 0.48 | Range: 34.6–41.6 |
| Initial body fat (%) | 45.9 | 95% CI ± 0.96 | |
| RYGB (Roux‐en‐Y gastric bypass) | 4 | ||
| VSG (vertical sleeve gastrectomy) | 3 | ||
| Abdominal banding | 0 | ||
| Any comorbidity | 79 (75.2%) | ||
| Depression and/or anxiety | 42 (40%) | ||
| Type 2 diabetes | 9 (8.5%) | ||
| Prediabetes | 12 (11.4%) | ||
| Hypertension | 28 (26.6%) | ||
| Hyperlipidemia | 21 (20%) | ||
| Vitamin D deficiency | 8 (7.6%) | ||
| Fatty liver | 8 (7.6%) | ||
| Osteoarthritis | 4 (3.8%) | ||
| Joint pain | 30 (28.6%) | ||
| Obstructive sleep apnea | 13 (12.4%) | ||
| Other comorbidities (gastroesophageal reflux disease, polycsystic ovarian syndrome, hypothyroidism, tachycardia, attention‐deficit/hyperactivity disorder, back pain, congestive heart failure, etc.) | 80 (76.1%) | ||